Skip to content
Screener

LeonaBio, Inc. LONA Q1 2026 Annual earnings

Reported May 7, 2026 · After market close

EPS-$1.73Beat by $0.55
EPS estimate-$2.28

Next report

Nov 5, 2026 (in 2 months)
EPS estimate-$0.69

Financials

Q1 2026

Income statement

See full
Operating income-$17.2M-80.5%
Net income-$32.9M-260%
EPS (diluted)-$1.73+26.1%

Balance sheet

See full
Cash & equivalents$32.8M+24.3%
Total debt$691.0K-38.2%
Total equity$49.3M+32.1%
Total assets$71.6M+64.5%

Cash flow

See full
Operating cash flow-$20.9M-42.5%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$95.97M—
Enterprise value$63.83M—

Returns & leverage

See full
Return on equity-298.8%-726pp
Debt / equity0×0.0×
Current ratio10.4×+3.1×

FAQ

When did LeonaBio, Inc. report Q1 2026 earnings?
LeonaBio, Inc. (LONA) reported Q1 2026 earnings on May 7, 2026 after market close.
What were LeonaBio, Inc.'s Q1 2026 revenue and EPS?
LeonaBio, Inc. reported eps of $-1.73 for Q1 2026.
Did LeonaBio, Inc. beat estimates in Q1 2026?
EPS beat the consensus estimate of $-2.28 by $0.55.
How did LeonaBio, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 652.2% from $-0.23.
Where can I find LeonaBio, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-211867) and the 10-K periodic report (0001193125-26-134565) directly on SEC EDGAR. The filing index links above go to sec.gov.